Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 30,278 | 10,973 | -9,344 | -4,815 | 21,591 |
| Depreciation Amortization | 11,524 | 8,683 | 5,805 | 2,897 | 11,519 |
| Income taxes - deferred | -7,075 | N/A | N/A | N/A | N/A |
| Accounts receivable | 16,345 | -6,685 | 19,805 | 23,143 | -8,368 |
| Accounts payable and accrued liabilities | -1,380 | 620 | 6,611 | 2,075 | 449 |
| Other Working Capital | -3,535 | -2,717 | 11,446 | 10,677 | -17,854 |
| Other Operating Activity | -7,239 | 12,437 | -22,050 | -22,731 | 19,672 |
| Operating Cash Flow | $38,918 | $23,311 | $12,273 | $11,246 | $27,009 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -56 | -40 | -20 | N/A | -140 |
| Purchase Of Investment | -76,230 | -60,956 | -44,892 | -24,974 | -23,813 |
| Sale Of Investment | 55,848 | 42,878 | 26,535 | 5,894 | 17,328 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -12,500 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -12,500 |
| Investing Cash Flow | $-20,438 | $-18,118 | $-18,377 | $-19,080 | $-19,125 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -33,330 | -22,220 | -11,110 | N/A | N/A |
| Common Stock Issued | 150 | 150 | N/A | N/A | N/A |
| Other Financing Activity | -666 | -445 | -222 | 0 | 0 |
| Financing Cash Flow | $-33,846 | $-22,515 | $-11,332 | $N/A | $N/A |
| Beginning Cash Position | 86,676 | 86,676 | 86,676 | 86,676 | 78,792 |
| End Cash Position | 71,310 | 69,354 | 69,240 | 78,842 | 86,676 |
| Net Cash Flow | $-15,366 | $-17,322 | $-17,436 | $-7,834 | $7,884 |
| Free Cash Flow | |||||
| Operating Cash Flow | 38,918 | 23,311 | 12,273 | 11,246 | 27,009 |
| Capital Expenditure | -56 | -40 | -20 | N/A | -140 |
| Free Cash Flow | 38,862 | 23,271 | 12,253 | 11,246 | 26,869 |